WL-276, an Antagonist against Bcl-2 Proteins, Overcomes sorted by
relevance

Admin30.07.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

9106
Admin12.08.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

6301
Admin12.09.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

6400
Admin10.08.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

1307
Admin27.09.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

7109
Admin03.09.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

6504
Admin09.10.2021

WL-276, an Antagonist against Bcl-2 Proteins, Overcomes

9503
Admin30.09.2021

The resistance of Granta-519 cells to VSV oncolysis is

6902
Admin09.08.2021

PPP overcomes the Bcl-2 dependency of ABT-737 . A-B

9006
Admin19.07.2021

UCMSC co-culture overcomes the drug-induced apoptosis of

3007
Admin06.10.2021

Strategic Therapeutic Targeting to Overcome Venetoclax

Admin19.07.2021

Sophie ZIEGLER | Research Associate / PhD Student | MSc

Admin20.09.2021

Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737

8506
Admin03.08.2021

(PDF) The thiol crosslinking agent diamide overcomes the

6706
Admin04.08.2021

Maria FEOKTISTOVA | PhD | Universität Heidelberg

1404
Admin28.09.2021

Deregulated BCL-2 family proteins impact on repair of DNA

Admin31.08.2021

Sophie ZIEGLER | Research Associate / PhD Student | MSc

4801
Admin24.07.2021

(PDF) Downregulation of Bcl-2, FLIP or IAPs (XIAP and

8607
Admin09.10.2021

(PDF) Combined venetoclax and alvocidib in acute myeloid

7207
Admin11.08.2021

Amy BAXTER | Research Officer | Doctor of Philosophy | La

40010
Admin10.09.2021

Induction of tumor necrosis factor by bryostatin 1 is

7406